Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia.
Nicci
C
C
Ottaviani
E
E
Luatti
S
S
Grafone
T
T
Tonelli
M
M
Motta
M R
MR
Malagola
M
M
Marzocchi
G
G
Martinelli
G
G
Baccarani
M
M
Testoni
N
N
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics*; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D020732:Cytogenetic Analysis; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D008297:Male; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000096:biosynthesis / Q000235:genetics*; D023981:Sarcoma, Myeloid / Q000150:complications*; D014178:Translocation, Genetic
D000970:Antineoplastic Agents; D018398:Homeodomain Proteins; C120276:NPM-RARalpha protein, human; D009363:Neoplasm Proteins; D015513:Oncogene Proteins; D015514:Oncogene Proteins, Fusion; C489494:TLX3 protein, human